Timothy Burcham and Steven Arnold

Lasergen has appointed Timothy Burcham as its CTO. He will help develop the firm's sequencing platform. Burcham has been a member of the firm's scientific advisory board since 2015, and previously spent time developing and launching sequencing systems at Applied Biosystems. The firm also plans to rearrange its board to accommodate three seats from Agilent and will add Steven Arnold, a management consultant who also serves on the board at Houston Methodist Research Institute and Texas Children's Hospital Cancer Center.